<乌鸦传媒>The Unfulfilled Promise of Cannabis for Cancer-Related Symptoms Medical cannabis is currently too far removed from the standards of medical practice Jan 14, 2023
<乌鸦传媒>For People With HIV, Early Anal Cancer Screening Tied to Better Outcomes All people with HIV should be screened, not just men who have sex with men, researchers say Jan 13, 2023
<乌鸦传媒>Off-the-Shelf T-Cell Therapy Effective Against Viral Infections After Allo-HCT Produced an antiviral response in 95% of patients with six different types of infection Jan 13, 2023
<乌鸦传媒>MRI-Guided Focused Ultrasound Eases Pain From Bone Metastases More responses with ultrasound, but quality-of-life scores lower vs EBRT in nonrandomized trial Jan 11, 2023
<乌鸦传媒>Study Supports Routine Omentectomy in Absence of Metastasis During CRS-HIPEC High rate of occult metastases in patients with grossly normal omentum Jan 11, 2023
<乌鸦传媒>Bariatric Surgery May Reduce Risk of Esophageal, Gastric Cancers Cohort study provides "reassurance of the protective clinical benefits of weight loss surgery" Jan 11, 2023
<乌鸦传媒>Zanubrutinib Shows Good Tolerance in BTK-Inhibitor Intolerant Malignancies Most patients had no recurrence of their original intolerance event Jan 10, 2023
<乌鸦传媒>Post-HSCT Brentuximab Vedotin Plus Nivolumab Highly Effective in Hodgkin Lymphoma However, toxic effects might limit the combination to the highest-risk patients Jan 10, 2023
<乌鸦传媒>Conspiracy Theorists' Cancer Beliefs; HIV Meds and Ethnicity Also in TTHealthWatch: sodium levels and health outcomes Jan 07, 2023 podcast
<乌鸦传媒>Genomic Assay May Pinpoint Who Can Skip RT After Breast-Conserving Surgery Patients categorized as low risk with 16-gene signature showed no significant benefit with RT Jan 06, 2023
<乌鸦传媒>More Evidence to Support Restrictive Opioid Prescribing After Cancer Surgery Significant decreases in prescription days, doses, refill requests, with few patient complaints Jan 06, 2023
<乌鸦传媒>Optimizing Treatment for Older Patients With HR+ Low-Risk Breast Cancer Five days of radiotherapy, five years of hormonal therapy, or somewhere in between? Jan 05, 2023
<乌鸦传媒>More Extensive Resection of Low-Grade Glioma Linked to Longer Survival Across both subtypes, improved survival seen with at least 75% resection, study finds Jan 05, 2023
<乌鸦传媒>Watch for New Psych Disorders in the Spouses of Cancer Patients Risk especially high within the first year after cancer diagnosis Jan 05, 2023
<乌鸦传媒>Jazz Musician With Slowly Expanding Neck Mass Causing Dysphagia Alcoholism, liver dysfunction highly linked with rare disease of unknown etiology Jan 04, 2023
<乌鸦传媒>Can Dying Well Be a Part of Living Well? Shoshana Ungerleider, MD, on her mission to transform end-of-life care Jan 03, 2023 podcast
<乌鸦传媒>Crystal Ball Cloudy for PI3K Inhibitors' Future in Hematology After a year of negative news, some caution about throwing out the baby with the bath water Jan 02, 2023
<乌鸦传媒>Adagrasib Shows Anti-Tumor Activity in Heavily Pretreated KRAS-Mutant CRC Response rates of 19% alone, 46% with cetuximab in phase I/II trial Dec 21, 2022
<乌鸦传媒>Early Win for Gene Therapy in Rare Form of SCID 10 infants were able to make their own T cells; safety good so far Dec 21, 2022
<乌鸦传媒>Mixed Results With Hormonal Strategies for Premenopausal Breast Cancer Exemestane reduced recurrence, metastasis versus tamoxifen, but no survival benefit Dec 20, 2022
<乌鸦传媒>Long-Term Data Reinforce Targeted Combo Versus Single Agent for Advanced Melanoma Encorafenib-binimetinib tops vemurafenib, but checkpoint inhibitors remain first-line choice Dec 19, 2022
<乌鸦传媒>OS Benefit Eludes Second-Line Niraparib Maintenance in Ovarian Cancer Significant PFS results demonstrated in NORA trial don't extend to overall survival Dec 17, 2022
<乌鸦传媒>FDA Approves First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Half of patients achieved complete responses with adenoviral vector-based product Dec 16, 2022
<乌鸦传媒>Anti-PD-1 Drugs Impress as Frontline Therapy for Early, Unfavorable Hodgkin's 3-year PFS of 99%, OS of 100% with nivolumab-chemo, high response rate with pembrolizumab Dec 16, 2022
<乌鸦传媒>No Blaming Common Antihypertensives for Pancreatic Cancer, Study Suggests Some reassurance on widely prescribed dihydropyridine calcium channel blockers Dec 15, 2022
<乌鸦传媒>New Regimen for GvHD Prophylaxis in Well-Matched Reduced-Intensity Allo-HCT Post-transplant cyclophosphamide, tacrolimus, and MMF reduces GvHD without higher relapse risk Dec 14, 2022
<乌鸦传媒>'Practice-Changing' Results With Zanubrutinib Versus Ibrutinib in CLL/SLL Significantly longer PFS with second-gen BTK inhibitor in relapsed/refractory disease Dec 14, 2022
<乌鸦传媒>C3 Pathway Inhibitor May Change Practice for Paroxysmal Nocturnal Hemoglobinuria Iptacopan improved hemoglobin without transfusion versus current standard of care Dec 14, 2022
<乌鸦传媒>High-Dose Chemo, ASCT Improves Survival in Primary CNS Lymphoma European trial is "practice-changing as of today," says U.S. expert Dec 13, 2022
<乌鸦传媒>Prolonged Responses in DLBCL Spark Talk of a Cure With Bispecific Antibody Most complete responses lasted 24 months or longer after limited-duration glofitamab Dec 13, 2022
<乌鸦传媒>Blinatumomab-Chemo Consolidation a 'New Standard' in MRD-Negative B-ALL Phase III study showed 58% reduction in the risk of death versus chemo alone Dec 13, 2022
<乌鸦传媒>Pediatric Hodgkin Lymphoma Survivors Experience Accelerated Epigenetic Aging Data from St. Jude cohort show higher rates of neurocognitive impairment Dec 13, 2022
<乌鸦传媒>Direct-Acting Antivirals Linked to Improved Outcomes in Chronic Hepatitis C All-cause mortality rate significantly lower in treated versus untreated group Dec 13, 2022
<乌鸦传媒>Durable Platelet Response in Immune Thrombocytopenia With Efgartigimod Glycoprotein receptor inhibitor produces four times as many responses as placebo Dec 12, 2022
<乌鸦传媒>Black Patients Less Likely to Get Advanced Treatments for PE Also less likely for patients on Medicare and Medicaid Dec 12, 2022
<乌鸦传媒>AML Study Suggests Intensive Chemo Unnecessary Before Allo-HCT Similar outcomes if patients went directly to transplant or received intensive salvage first Dec 11, 2022
<乌鸦传媒>Talquetamab Offers New Hope in Relapsed/Refractory Multiple Myeloma Bispecific antibody achieves "incredible" response rates over 70% in heavily pretreated patients Dec 11, 2022
<乌鸦传媒>Ibrutinib Makes Its Case for First-Line Treatment in Mantle Cell Lymphoma Standard-of-care autologous transplant fails to prove superior to BTK inhibitor alone Dec 11, 2022
<乌鸦传媒>Rigid In-Hospital Diet Offers No Advantage in Patients After HSCT "We should eliminate these silly neutropenic diets," expert says Dec 10, 2022
<乌鸦传媒>Higher Brain Cancer Risk After CT Exam in Childhood Study suggests one radiation-induced brain cancer expected per 10,000 persons receiving a head CT Dec 09, 2022
